- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Teleflex Incorporated (TFX)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/02/2025: TFX (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $124.14
1 Year Target Price $124.14
| 0 | Strong Buy |
| 2 | Buy |
| 11 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.67% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.13B USD | Price to earnings Ratio - | 1Y Target Price 124.14 |
Price to earnings Ratio - | 1Y Target Price 124.14 | ||
Volume (30-day avg) 14 | Beta 0.95 | 52 Weeks Range 102.26 - 186.79 | Updated Date 12/3/2025 |
52 Weeks Range 102.26 - 186.79 | Updated Date 12/3/2025 | ||
Dividends yield (FY) 1.19% | Basic EPS (TTM) -7.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-06 | When - | Estimate 3.38 | Actual 3.67 |
Profitability
Profit Margin -10.28% | Operating Margin (TTM) 12.4% |
Management Effectiveness
Return on Assets (TTM) 4.94% | Return on Equity (TTM) -7.9% |
Valuation
Trailing PE - | Forward PE 7.58 | Enterprise Value 7471439219 | Price to Sales(TTM) 1.61 |
Enterprise Value 7471439219 | Price to Sales(TTM) 1.61 | ||
Enterprise Value to Revenue 2.34 | Enterprise Value to EBITDA 142.75 | Shares Outstanding 44194408 | Shares Floating 41709356 |
Shares Outstanding 44194408 | Shares Floating 41709356 | ||
Percent Insiders 0.33 | Percent Institutions 108.28 |
Upturn AI SWOT
Teleflex Incorporated

Company Overview
History and Background
Teleflex Incorporated was founded in 1943 as a manufacturer of mechanical remote control systems. Over the years, it has evolved through acquisitions and organic growth to become a global provider of medical technology products and services.
Core Business Areas
- Vascular Solutions: This segment develops, manufactures, and markets a range of devices used in interventional cardiology and radiology procedures, including guide wires, catheters, and access devices.
- Interventional Urology: This segment provides solutions for urological procedures, including devices for managing enlarged prostates and urinary obstructions.
- Surgical Solutions: Offers specialized surgical instruments, sutures, and ligation devices for various surgical specialties.
- Anesthesia: Provides a range of anesthesia and respiratory products, including laryngeal masks and airway management devices.
- OEM: Teleflex partners with OEM clients to provide component assembly and finished medical devices
Leadership and Structure
Teleflex is led by Liam J. Kelly (Chairman, President and CEO). The company has a hierarchical organizational structure with various business units reporting to executive leadership.
Top Products and Market Share
Key Offerings
- Arrow EZ-IO Intraosseous Vascular Access System: A device used to establish immediate vascular access in emergency situations. Competitors include Vidacare (Teleflex acquired them) and PerSys Medical. Market share difficult to pinpoint exactly, but it's a significant player in the IO access market.
- LMA Airway Management Devices: A range of laryngeal mask airways used for anesthesia and airway management. Competitors include Ambu and Smiths Medical. Teleflex holds a significant market share in the global laryngeal mask airway market.
- UroLift System: A minimally invasive technology for treating enlarged prostates (BPH). Competitors include Boston Scientific (ProAccess) and Olympus (Plasma Resection). UroLift is a key product driving growth in Interventional Urology.
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulation, and consolidation. Demand is driven by an aging population, increasing prevalence of chronic diseases, and technological advancements.
Positioning
Teleflex is positioned as a diversified medical technology company focused on niche markets and minimally invasive procedures. Its competitive advantages include a strong portfolio of branded products, established distribution channels, and a focus on innovation.
Total Addressable Market (TAM)
The total addressable market across Teleflex's segments is estimated to be several billion dollars annually. Teleflex is well-positioned to capture a significant portion of this market through product innovation and market expansion.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Strong brands in key market segments
- Focus on minimally invasive procedures
- Established distribution channels
- History of successful acquisitions
Weaknesses
- Dependence on certain key products
- Exposure to regulatory risks
- Integration challenges with acquisitions
- Competition from larger medical device companies
- Currency exchange rate fluctuation
Opportunities
- Expansion into emerging markets
- Development of new products and technologies
- Strategic acquisitions to expand product portfolio
- Increased adoption of minimally invasive procedures
- Partnerships and collaborations with other healthcare providers
Threats
- Increased competition from established and emerging players
- Pricing pressures from healthcare providers
- Changes in healthcare regulations and reimbursement policies
- Product liability lawsuits
- Economic downturns affecting healthcare spending
Competitors and Market Share
Key Competitors
- BSX
- MDT
- ABT
- BMRN
Competitive Landscape
Teleflex competes with larger medical device companies in many of its segments. It differentiates itself through its focus on niche markets, branded products, and minimally invasive procedures.
Major Acquisitions
Standard Bariatrics, Inc.
- Year: 2022
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expanded the company's bariatric surgery solutions and strengthened the surgical solutions segment.
Growth Trajectory and Initiatives
Historical Growth: Teleflex has historically grown through organic growth and strategic acquisitions.
Future Projections: Future growth projections depend on market conditions and analyst predictions. Refer to equity research reports.
Recent Initiatives: Recent initiatives include new product launches, strategic acquisitions, and cost optimization programs.
Summary
Teleflex is a well-positioned medical technology company with a diversified portfolio and a focus on minimally invasive procedures. Its growth strategy relies on innovation, acquisitions, and expansion into emerging markets. Regulatory risks and competition remain key challenges. Financials need to be observed directly on the company websites for accurate assessment. While they appear sound, individual performance must be validated through the use of their direct website. The company focuses on driving shareholder value and has a strong team running the company.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Teleflex Investor Relations
- SEC Filings (10-K, 10-Q)
- Equity Research Reports
- Industry Analysis Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial advisor. Market share data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Teleflex Incorporated
Exchange NYSE | Headquaters Wayne, PA, United States | ||
IPO Launch date 1988-02-18 | Chairman, President & CEO Mr. Liam J. Kelly | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 14100 | Website https://www.teleflex.com |
Full time employees 14100 | Website https://www.teleflex.com | ||
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

